Showing results 51 - 60 of 236
GJE is excited to announce that the firm has joined the climate tech community Climate Connection as a Community Partner....
What do business owners need to do to protect their brand value and combat copycats?...
GJE is pleased to announce that the firm has formed an alliance with the German patent and trade mark firm Wächtershäuser & Hartz (W&H)...
Read our June 2025 patent law update, including updates from the UK, the European Patent Office (EPO) and the WIPO/PCT...
We set out the key things for innovators and applicants to consider when patenting gene editors in Europe....
UKIPO update Series marks to be abolished As a result of the second transformation consultation by the UKIPO, it was decided that series marks would be abolished. In its press release, it was explaine...
Technology review The impact of gene therapies has been revolutionary to the treatment of genetic disorders and diseases. Unlike traditional pharmaceuticals, which typically treat symptoms, gene thera...
Read our May 2025 patent law update, including updates from the UK, the European Patent Office (EPO) and the WIPO/PCT...
Technology overview Bispecific monoclonal antibodies (BsAbs) are antibody constructs that create additional strategies in designing therapeutic avenues due to their ability to bind two different targe...
Read our April 2025 patent law and practice updates, including updates from the UK, the European Patent Office (EPO) and the WIPO/PCT...